H. Gerlach

Prevention of thromboembolic complications in patients with superficial-vein thrombosis given rivaroxaban or fondaparinux: the open-label, randomised, non-inferiority SURPRISE phase 3b trial

Jan Beyer‐Westendorf, Sebastian Schellong, H. Gerlach et al. · The Lancet Haematology · 2017 · 171 citations

Medicine, Pharmacotherapy, Clinical Pharmacology +11

Guidelines for Sclerotherapy of Varicose Veins (ICD 10: I83.0, I83.1, I83.2, and I83.9)

Eberhard Rabe, F. Pannier-Fischer, H. Gerlach et al. · Dermatologic Surgery · 2004 · 95 citations

Medicine, Surgery, Microsurgery +11

Impact of gender on the clinical presentation and diagnosis of deep-vein thrombosis

Hanno Riess, V. Hach-Wunderle, H. Gerlach et al. · Thrombosis and Haemostasis · 2010 · 54 citations

Medicine, Internal Medicine, Men's Health +7

Management and Outcomes of Patients with Isolated Superficial Vein Thrombosis under Real Life Conditions (INSIGHTS-SVT)

Rupert Bauersachs, H. Gerlach, Andreas Heinken et al. · European Journal of Vascular and Endovascular Surgery · 2021 · 48 citations · Full text

Medicine, Orthopaedic Surgery, Surgery +17

Diagnosis of deep-vein thrombosis: Adherence to guidelines and outcomes in real-world health care

H. Gerlach, V. Hach-Wunderle, Eberhard Rabe et al. · Thrombosis and Haemostasis · 2009 · 44 citations

Medicine, Hematology, Internal Medicine +17